| UniProt ID | PHB_HUMAN | |
|---|---|---|
| UniProt AC | P35232 | |
| Protein Name | Prohibitin | |
| Gene Name | PHB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 272 | |
| Subcellular Localization | Mitochondrion inner membrane. | |
| Protein Description | Prohibitin inhibits DNA synthesis. It has a role in regulating proliferation. As yet it is unclear if the protein or the mRNA exhibits this effect. May play a role in regulating mitochondrial respiration activity and in aging.. | |
| Protein Sequence | MAAKVFESIGKFGLALAVAGGVVNSALYNVDAGHRAVIFDRFRGVQDIVVGEGTHFLIPWVQKPIIFDCRSRPRNVPVITGSKDLQNVNITLRILFRPVASQLPRIFTSIGEDYDERVLPSITTEILKSVVARFDAGELITQRELVSRQVSDDLTERAATFGLILDDVSLTHLTFGKEFTEAVEAKQVAQQEAERARFVVEKAEQQKKAAIISAEGDSKAAELIANSLATAGDGLIELRKLEAAEDIAYQLSRSRNITYLPAGQSVLLQLPQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAKVFESI ------CCHHHHHHH | 18.91 | 25944712 | |
| 4 | Methylation | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | 23644510 | |
| 4 | Acetylation | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | 25825284 | |
| 4 | Ubiquitination | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | - | |
| 4 | Succinylation | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | 23954790 | |
| 4 | Ubiquitination | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | - | |
| 4 | Methylation | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | - | |
| 4 | Acetylation | ----MAAKVFESIGK ----CCHHHHHHHHH | 37.61 | - | |
| 11 | Methylation | KVFESIGKFGLALAV HHHHHHHHHHHHHHH | 34.29 | 23644510 | |
| 11 | Methylation | KVFESIGKFGLALAV HHHHHHHHHHHHHHH | 34.29 | - | |
| 41 | Methylation | HRAVIFDRFRGVQDI CCEEEEECCCCCEEE | 16.65 | 115487351 | |
| 63 | Acetylation | FLIPWVQKPIIFDCR CEECCCCCCEEEECC | 28.68 | 26051181 | |
| 80 | Phosphorylation | PRNVPVITGSKDLQN CCCCCEEECCCCHHC | 35.32 | 20068231 | |
| 82 | Phosphorylation | NVPVITGSKDLQNVN CCCEEECCCCHHCCC | 17.85 | 20068231 | |
| 83 | Acetylation | VPVITGSKDLQNVNI CCEEECCCCHHCCCE | 64.90 | 26051181 | |
| 83 | Ubiquitination | VPVITGSKDLQNVNI CCEEECCCCHHCCCE | 64.90 | 21890473 | |
| 83 | Ubiquitination | VPVITGSKDLQNVNI CCEEECCCCHHCCCE | 64.90 | 21890473 | |
| 91 | Phosphorylation | DLQNVNITLRILFRP CHHCCCEEEHHHHHH | 12.55 | 30108239 | |
| 93 | Methylation | QNVNITLRILFRPVA HCCCEEEHHHHHHHH | 18.21 | 115487361 | |
| 101 | Phosphorylation | ILFRPVASQLPRIFT HHHHHHHHCCCHHHH | 32.27 | 30108239 | |
| 108 | Phosphorylation | SQLPRIFTSIGEDYD HCCCHHHHHCCCCCC | 19.64 | 20833797 | |
| 109 | Phosphorylation | QLPRIFTSIGEDYDE CCCHHHHHCCCCCCC | 20.18 | 28985074 | |
| 114 | Phosphorylation | FTSIGEDYDERVLPS HHHCCCCCCCCCCCH | 18.53 | 28152594 | |
| 121 | O-linked_Glycosylation | YDERVLPSITTEILK CCCCCCCHHHHHHHH | 28.53 | 19238206 | |
| 121 | Phosphorylation | YDERVLPSITTEILK CCCCCCCHHHHHHHH | 28.53 | 27050516 | |
| 123 | Phosphorylation | ERVLPSITTEILKSV CCCCCHHHHHHHHHH | 23.78 | 20833797 | |
| 124 | Phosphorylation | RVLPSITTEILKSVV CCCCHHHHHHHHHHH | 21.25 | 24641631 | |
| 128 | Ubiquitination | SITTEILKSVVARFD HHHHHHHHHHHHHCC | 47.03 | 21890473 | |
| 128 | Acetylation | SITTEILKSVVARFD HHHHHHHHHHHHHCC | 47.03 | - | |
| 128 | Succinylation | SITTEILKSVVARFD HHHHHHHHHHHHHCC | 47.03 | 27452117 | |
| 128 | Ubiquitination | SITTEILKSVVARFD HHHHHHHHHHHHHCC | 47.03 | 21890473 | |
| 128 | Acetylation | SITTEILKSVVARFD HHHHHHHHHHHHHCC | 47.03 | 23954790 | |
| 141 | O-linked_Glycosylation | FDAGELITQRELVSR CCCCHHCCHHHHHHH | 33.91 | 29351928 | |
| 151 | Phosphorylation | ELVSRQVSDDLTERA HHHHHHCCCHHHHHH | 19.64 | 30108239 | |
| 155 | Phosphorylation | RQVSDDLTERAATFG HHCCCHHHHHHHHHC | 30.35 | 30108239 | |
| 177 | Ubiquitination | LTHLTFGKEFTEAVE CCEEECCHHHHHHHH | 45.52 | - | |
| 186 | Ubiquitination | FTEAVEAKQVAQQEA HHHHHHHHHHHHHHH | 31.62 | 21890473 | |
| 186 | Acetylation | FTEAVEAKQVAQQEA HHHHHHHHHHHHHHH | 31.62 | 25953088 | |
| 202 | Ubiquitination | RARFVVEKAEQQKKA HHHHHHHHHHHHHHE | 45.68 | 21906983 | |
| 202 | Succinylation | RARFVVEKAEQQKKA HHHHHHHHHHHHHHE | 45.68 | - | |
| 202 | Malonylation | RARFVVEKAEQQKKA HHHHHHHHHHHHHHE | 45.68 | 26320211 | |
| 202 | Succinylation | RARFVVEKAEQQKKA HHHHHHHHHHHHHHE | 45.68 | - | |
| 202 | Acetylation | RARFVVEKAEQQKKA HHHHHHHHHHHHHHE | 45.68 | 19608861 | |
| 207 | Acetylation | VEKAEQQKKAAIISA HHHHHHHHHEEEEEC | 44.04 | 2402135 | |
| 208 | Succinylation | EKAEQQKKAAIISAE HHHHHHHHEEEEECC | 38.42 | 27452117 | |
| 208 | Ubiquitination | EKAEQQKKAAIISAE HHHHHHHHEEEEECC | 38.42 | - | |
| 213 | Phosphorylation | QKKAAIISAEGDSKA HHHEEEEECCCCHHH | 17.72 | 29255136 | |
| 218 | Phosphorylation | IISAEGDSKAAELIA EEECCCCHHHHHHHH | 34.74 | 21712546 | |
| 219 | Ubiquitination | ISAEGDSKAAELIAN EECCCCHHHHHHHHH | 57.25 | 21890473 | |
| 240 | Ubiquitination | DGLIELRKLEAAEDI CCHHHHHHHHHHHHH | 64.40 | 21890473 | |
| 249 | Phosphorylation | EAAEDIAYQLSRSRN HHHHHHHHHHHCCCC | 15.43 | 27273156 | |
| 252 | Phosphorylation | EDIAYQLSRSRNITY HHHHHHHHCCCCCEE | 16.82 | 21082442 | |
| 254 | Phosphorylation | IAYQLSRSRNITYLP HHHHHHCCCCCEEEC | 26.71 | 22817900 | |
| 258 | Phosphorylation | LSRSRNITYLPAGQS HHCCCCCEEECCCCE | 23.66 | 22410782 | |
| 258 | O-linked_Glycosylation | LSRSRNITYLPAGQS HHCCCCCEEECCCCE | 23.66 | 19238206 | |
| 259 | Phosphorylation | SRSRNITYLPAGQSV HCCCCCEEECCCCEE | 13.59 | 19238206 | |
| 265 | Phosphorylation | TYLPAGQSVLLQLPQ EEECCCCEEEECCCC | 17.51 | 19060867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 114 | Y | Phosphorylation | Kinase | INSR | P06213 | PSP |
| 258 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 258 | T | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
| 259 | Y | Phosphorylation | Kinase | KIT | P10721 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:24658274 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHB_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-202, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-254, ANDMASS SPECTROMETRY. | |